Precision Biosciences Inc (DTIL) Institutional Ownership

Ownership Summary

Precision Biosciences Inc (NASDAQ:DTIL) showed up in the 13F filings of 69 institutional investors as of December 2025.

• These investors collectively held 127.8% of Precision Biosciences's outstanding shares in December 2025, up from 39.3% in September 2025.
• They increased total shares held in Precision Biosciences by 287.24% from last quarter, and the number of investors in DTIL increased 25.45% annually.
• During the quarter, 43 of these 69 funds increased positions in DTIL, 8 reduced exposure, and 18 held steady.
• The aggregate institutional position in Precision Biosciences amounted to 15.11Mn shares as of December 2025, up by 11.21Mn shares quarter on quarter, and up 11.31Mn shares year over year.
• Octagon Capital Advisors LP holds the largest position in DTIL at 2.24Mn shares as of December 31, 2025, or 18.93% of shares outstanding.
• The biggest buyers of Precision Biosciences for the quarter ending December 2025 included VANGUARD CAPITAL MANAGEMENT LLC (910.74K), Affinity Asset Advisors, LLC (597.95K), MARSHALL WACE, LLP (344.76K), Octagon Capital Advisors LP (318.74K), DRIEHAUS CAPITAL MANAGEMENT LLC (207.67K).
• Top sellers of DTIL stock for the quarter ending December 2025 included Alyeska Investment Group, L.P. (659.18K), SPHERA FUNDS MANAGEMENT LTD. (356.12K), Empery Asset Management, LP (225.76K), RENAISSANCE TECHNOLOGIES LLC (103.3K), Quadrature Capital Ltd (29.85K).
• Business Quant data shows the 10 biggest positions in Precision Biosciences as of December 2025 are held by Octagon Capital Advisors LP (2.24Mn), Aberdeen Group plc (2.23Mn), Empery Asset Management, LP (1.97Mn), Bleichroeder LP (1.66Mn), BOOTHBAY FUND MANAGEMENT, LLC (1.07Mn), DRIEHAUS CAPITAL MANAGEMENT LLC (995.37K), Lynx1 Capital Management LP (985.11K), VANGUARD CAPITAL MANAGEMENT LLC (910.74K), Affinity Asset Advisors, LLC (597.95K), MARSHALL WACE, LLP (415.67K).